SeQuent Scientific Appoints Pharmaceutical Industry Leader Rajaram Narayanan as Managing Director and CEO
Acquisition of Nourrie
SeQuent announced EUGMP approval for its tablets dosage form in Turkey
SeQuent Scientific Ltd Press Release Q4 FY21
SeQuent received CEP approval for Diclazuril API
Corporate update – December 22, 2020
Investors/analysts Conference Call – Corporate Update – December 22, 2020
SeQuent announced launch of Citramox® LA in EU
Launch of inhouse developed Halofusol® in EU
SeQuent Scientific Ltd PR Q2 FY21
SeQuent Announces Reconstitution of Board
SeQuent Scientific provides Covid-19 and Business Update
Sequent Scientific announces WHO-Geneva approval for its Vizag facility
Sequent Scientific announces addition of new state-of-art Animal Health R&D Centre at Mumbai
SeQuent Scientific receives EIR from US FDA for its Analytical Laboratory at Bengaluru
Earnings Transcript May 14, 2019
SeQuent Scientific Announces Q4 and Annual FY19 Financial
Change in Credit Rating
Earning Transcripts February 1, 2019
Sequent financials press release SeQuent Scientific Announces Q3 FY19 Financial Results
SeQuent Scientific Ltd. receives EIR from USDFA for its Analytical Lab at Mangalore
Earning Transcripts November 2, 2018
SeQuent Scientific Announces Q2 FY19 Financial Results
Earning Transcripts August 10 2018
SeQuent Scientific Announces Q1 FY19 Financial Results
Sequent Scientific Earnings Transcript Q4 FY 18 Financial Results
SeQuent Scientific Announces Q4 FY18 Financial Results alongwith Investors Presentation
SeQuent Scientific Announces Q3 FY18 Financial Results
Sequent Scientific Announces Q2 FY 18 Financial Results
Sequent Scientific Announces Q1 FY 18 Financial Results
SeQuent Scientific announces FY17 Financial Results
Establishment Inspection Report - Visakhapatnam (Vizag) Plant
SeQuent Scientific announces Q3FY17 Financial Results
SeQuent Scientific to become a pur-play Animal Health Company
SeQuent Scientific announces Q2FY17 Financial Results
SeQuent Scientific announces Q1FY17 Financial Results
Alivira completes the acquisition of 70% stake in Interchange, Brazil
Alivira to acquire majority stake in Karizoo Group Spain
SeQuent Scientific announces FY16 Financial Results
Alivira to acquire controlling interest in Interchange Brazil
SeQuent Scientific Mahad Facility Receives Environment Clearance from SEIAA
SeQuent Scientific announces Q3FY16 Financial Results
Sequent Scientific to acquire controlling stake in Indo Phyto Chemicals Forays into steroids and hormones for Female Healthcare
Alivira forays into European Veterinary Market
Alivira to acquire Topkim, Turkey Will make Alivira the largest Animal Health Company of Turkey
SeQuent receives Establishment Inspection Report from US FDA for its API Drug Manufacturing Facility at Mangalore
SeQuent Scientific announces Q2FY16 Financial Results
SeQuent Scientific completes acquisition of Animal Health business of Lyka Exports
SeQuent Scientific to acquire Animal Health business of Lyka Exports
SeQuent Scientific announces Q1FY16 Financial Results
SeQuent Scientific completes fund raise of INR 4,000 mn through Qualified Institutional Placement
SeQuent Scientific announces Q4 - FY 2014-15 Results
SeQuent Scientific announces Q3 - FY 2014-15 Results
SeQuent Scientific announces Q2 - FY 2014-15 Results
SeQuent Scientific announces Q1 - FY 2014-15 Results
Sequent Scientific announces licensing agreement with Gilead Sciences, Inc for new Hepatitis C drug
Alivira Animal Health to acquire majority stake in Provet Veterinary Products AS of Turkey
SeQuent Scientific Limited announces completion of Sale of Specialty Chemicals division to Songwon Industrial Group
SeQuent Scientific announces FY 2013-14 Results
SeQuent Scientific to acquire the business of Arvee Synthesis
Songwon Industrial Group to acquire Specialty Chemicals Division of SeQuent Scientific Limited
SeQuent Scientific to acquire the business of Arvee Synthesis Acquisition to provide impetus to Human API business
Sequent Scientific Ltd & Shasun Pharmaceuticals Ltd Announce Joint Venture To Create Leading Animal Health Company
Sequent Scientific Receives Us Fda Approval For Its Api Drug Manufacturing Facility At Mangalore